Journal article
Development of Novel Activin-Targeted Therapeutics
Justin L Chen, Kelly L Walton, Sara L Al-Musawi, Emily K Kelly, Hongwei Qian, Mylinh La, Louis Lu, George Lovrecz, Mark Ziemann, Ross Lazarus, Assam El-Osta, Paul Gregorevic, Craig A Harrison
Molecular Therapy | CELL PRESS | Published : 2015
DOI: 10.1038/mt.2014.221
Grants
Awarded by National Health and Medical Research Council (NHMRC, Australia)
Awarded by NH&MRC Career Development Fellowships
Awarded by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
Funding Acknowledgements
Myostatin-null mice were a gift of Se-Jin Lee (Johns Hopkins University, Baltimore, MD). This work was supported by grant funding (526648, 566820) from the National Health and Medical Research Council (NH&MRC, Australia). CAH and PG are supported by NH&MRC Career Development Fellowships (1013533, 1046782 respectively). P.G. was previously supported by a Senior Research Fellowship sponsored by Pfizer Australia. An Endocrine Society of Australia Postdoctoral Fellowship Award supports K.L.W. MIMR-PHI Institute of Medical Research and The Baker IDI Heart & Diabetes Institute are supported in part by the Operational Infrastructure Support Program of the Victorian Government, Australia. The authors declare no conflict of interest.